Related Experiment Video
Updated: Feb 19, 2026

08:53
A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
Published on: September 15, 2021
3.3K
U6 snRNA expression prevents toxicity in TDP-43-knockdown cells
Masao Yahara1, Akira Kitamura1, Masataka Kinjo1
1Laboratory of Molecular Cell Dynamics, Faculty of Advanced Life Science, Hokkaido University, Sapporo, Japan.
Plos One
|November 11, 2017
Summary
Loss of TDP-43 protein in neurons disrupts U6 small nuclear RNA (snRNA) levels, leading to cell death. Restoring U6 snRNA levels can prevent this cell death, highlighting TDP-43's role in U6 snRNA regulation.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- The transactivation response (TAR) RNA/DNA-binding protein 43 kDa (TDP-43) is linked to amyotrophic lateral sclerosis (ALS).
- TDP-43 depletion affects RNA splicing and can cause neuronal cell death.
- The impact of TDP-43 depletion on small nuclear RNA (snRNA) expression and its connection to cell death is not fully understood.
Purpose of the Study:
- To investigate the relationship between TDP-43 depletion, snRNA expression alterations, and neuronal cell death.
- To determine if U6 snRNA downregulation is a cause or consequence of TDP-43 depletion-induced cell death.
Main Methods:
- TDP-43 was knocked down in murine neuroblastoma Neuro2A cells.
- snRNA levels (U1, U2, U4, U6) were quantified over time.
- Cell death was assessed following TDP-43 knockdown.
- U6 snRNA was exogenously expressed to observe its effect on cell death and splicing.
Main Results:
- A time lag was observed between TDP-43 depletion and cell death.
- U6 snRNA levels significantly decreased before significant cell death occurred.
- Downregulation of U6 snRNA induced cell death.
- Exogenous U6 snRNA expression counteracted TDP-43 knockdown-induced cell death and partially rescued mis-splicing of specific transcripts.
Conclusions:
- TDP-43 regulates U6 snRNA expression levels.
- U6 snRNA downregulation is a key mechanism contributing to cell death upon TDP-43 loss-of-function.
- Targeting U6 snRNA levels may offer a therapeutic strategy for TDP-43 proteinopathies.
Related Concept Videos
Experimental RNAi
7.8K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.8K
Nonsense-mediated mRNA Decay
12.0K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
12.0K
siRNA - Small Interfering RNAs
18.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.8K
RNA Interference
28.2K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.2K

